Have a personal or library account? Click to login
Higher Serum Uric Acid Levels in Multiple Sclerosis Patients After Longterm Interferon Beta Treatment Cover

Higher Serum Uric Acid Levels in Multiple Sclerosis Patients After Longterm Interferon Beta Treatment

EABR. Experimental and Applied Biomedical Research
Volume 18 (2017): Issue 3 (October 2017)
By: Gordana Toncev,  Katarina Vesic,  Dejan Aleksic and  Snežana Lazarevic  
Open Access
|Oct 2017

Authors

Gordana Toncev

Clinic of neurology, Clinical Center, Kragujevac, Serbia
Faculty of Medical Sciences, University of Kragujevac,, Kragujevac, Serbia

Katarina Vesic

Faculty of Medical Sciences, University of Kragujevac,, Kragujevac, Serbia

Dejan Aleksic

Faculty of Medical Sciences, University of Kragujevac,, Kragujevac, Serbia

Snežana Lazarevic

simovicsnezana2@gmail.com

Faculty of Medical Sciences, University of Kragujevac,, Kragujevac, Serbia
DOI: https://doi.org/10.1515/sjecr-2016-0052 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Journal RSS Feed
Language: English
Page range: 227 - 230
Submitted on: May 5, 2016
|
Accepted on: Jul 5, 2016
|
Published on: Oct 19, 2017
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
multiple sclerosis,
interferon beta,
uric acid
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2017 Gordana Toncev, Katarina Vesic, Dejan Aleksic, Snežana Lazarevic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 18 (2017): Issue 3 (October 2017)Next article